Akèy › Dyabèt
Etid klinik pou Dyabèt ap rekrite nan Etazini
207 etid pou Dyabèt ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA23 etid
- New York City, NY17 etid
- Houston, TX16 etid
- Chicago, IL15 etid
- Durham, NC14 etid
- Aurora, CO14 etid
- Baltimore, MD13 etid
- Philadelphia, PA12 etid
- Indianapolis, IN10 etid
- San Diego, CA10 etid
- Los Angeles, CA10 etid
- Washington, DC10 etid
- Miami, FL9 etid
- Minneapolis, MN9 etid
- Queens, NY9 etid
- Birmingham, AL9 etid
- Pittsburgh, PA9 etid
- Phoenix, AZ9 etid
- Columbus, OH9 etid
- Orlando, FL8 etid
- Mountain View, CA8 etid
- Dallas, TX7 etid
- San Antonio, TX7 etid
- Atlanta, GA6 etid
- Seattle, WA6 etid
- San Francisco, CA6 etid
- Rochester, MN6 etid
- Cleveland, OH5 etid
- Memphis, TN5 etid
- Ann Arbor, MI5 etid
- Tucson, AZ5 etid
- Jacksonville, FL5 etid
- Gainesville, FL5 etid
- St. Louis, MO5 etid
- Concord, CA5 etid
- Albuquerque, NM5 etid
- The Bronx, NY5 etid
- New Haven, CT5 etid
- Edison, NJ5 etid
- Nashville, TN5 etid
Pa eta
- Alabama13 etid
- Arizona13 etid
- Colorado16 etid
- Connecticut8 etid
- Distrik Columbia4 etid
- Florid28 etid
- Georgia11 etid
- Illinois19 etid
- Indiana12 etid
- Iowa3 etid
- Kalifòni41 etid
- Kansas4 etid
- Kentucky4 etid
- Lwizyàn7 etid
- Maryland19 etid
- Massachusetts28 etid
- Michigan12 etid
- Minnesota15 etid
- Missouri10 etid
- Nebraska4 etid
- Nevada3 etid
- New Jersey9 etid
- New Mexico6 etid
- New York27 etid
- North Carolina24 etid
- Ohio17 etid
- Oklahoma4 etid
- Oregon3 etid
- Pennsylvania20 etid
- Rhode Island5 etid
- South Carolina9 etid
- Tennessee12 etid
- Texas28 etid
- Virginia11 etid
- Washington9 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06724406Diabetes and Heart Disease Risk in Blacks
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001853Obstructive Sleep Apnea Among Somali-Americans
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT04124848New Heart Imaging Techniques to Evaluate Possible Heart Disease
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01399385A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549Early Tracking of Childhood Health Determinants (ETCHED) Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 99 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT03481829Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06759701Lifestyle Change Implementation Research Network at PRC at UMass Chan
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07481305A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)
Ap rekrite
Laj 22 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07355270Urinary Vitamin C Loss in Diabetic Subjects
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT00071526Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Taste Bud-Derived Stem Cells in Humans
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT03366168Personalized Environment and Genes Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT00341237Caregiving Networks Across Disease Context and the Life Course
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05007990A Natural History Study of Metabolic Sizing in Health and Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 99 · Tout sèks · Mizajou Sep 15, 2026 · NCT05398783CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Ap rekriteFaz 1/2
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309Impact GLP-1 Agonists Following Bariatric
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06132477DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06104969Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Sep 9, 2026 · NCT07032844SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
Ap rekriteFaz 1 bonè
Laj 14 a 24 · Tout sèks · Mizajou Sep 9, 2026 · NCT07409714C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07807280Inflammation, Diabetes, Ethnicity and Obesity Cohort
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT03022682Improving Coronary Vascular Health in Women
Ap rekriteFaz 2
Laj 45 a 75 · Fanm · Mizajou Sep 8, 2026 · NCT06843902The iLet Experience Study
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06891898Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.